Healthcare reform and a desire for universal healthcare are key components of the 13th Five-Year Plan and require commercial industry investment. China acknowledged these goals are dependent on efficient evaluation and approval procedures for medical devices and pharmaceuticals, improved research and development (R&D) of new medicines, and a successful, advanced online system for healthcare management and...
China Market Intelligence
Top Stories
April 27th, 2016
China recently issued new rules that that offer mixed implications for foreign company qualification for innovation-related tax breaks. Eligibility criteria for a reduced corporate tax rate were tightened by stricter intellectual property (IP) requirements, but the scope of research and development (R&D) expenses that can be written off was loosened.
High- and New-Technology Enterprise (HNTE) IP and...